A retrospective multicenter cohort study of Antigen Directed Therapy Compared to Conventional Chemotherapy in Pediatric Patients with Relapsed and Refractory B-cell acute lymphoblastic leukemia
Latest Information Update: 16 Jan 2023
At a glance
- Drugs Blinatumomab (Primary) ; CAR-T cell therapies (Primary) ; Inotuzumab ozogamicin (Primary)
- Indications B-cell leukaemia; Precursor B-cell lymphoblastic leukaemia-lymphoma
- Focus Adverse reactions; Therapeutic Use
- 16 Jan 2023 New trial record
- 13 Dec 2022 Results presented at the 64th American Society of Hematology Annual Meeting and Exposition